ACUTE ISCHEMIC STROKE (AIS) MARKET ANALYSIS

Acute Ischemic Stroke (AIS) Market, By Therapeutics (Tissue Plasminogen Activator, Anticoagulant, Antiplatelet, Antihypertensive), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies , Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Oct 2023
Code : CMI4483
Pages :149
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Acute Ischemic Stroke (AIS) Market- Key Players

Major players operating in the global acute ischemic stroke (AIS) market include F. Hoffmann-La Roche Ltd, Boehringer Ingelheim International GmbH, Bayer AG, Pfizer Inc., Biogen, DAIICHI SANKYO COMPANY, LIMITED, Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., AstraZeneca, SanBio Co,Ltd., Athersys, Inc., Abbott, Sanofi, ZZ Biotech, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc., NoNO Inc., AliveCor, Inc., Amgen Inc., Genentech USA, Inc., DiaMedica Therapeutics, Inc.